CopyMark Law Group
4.9/5
Drawing for A ALS ASSOCIATION TREAT ALS TRANSLATIONAL RESEARCH ADVANCING THERAPY FOR ALS

USPTO serial 77175275

A ALS ASSOCIATION TREAT ALS TRANSLATIONAL RESEARCH ADVANCING THERAPY FOR ALS

Reviewed by CopyMark Law Group

Reg. 3577008Status 710
Filing date
Status date
Registration date
Feb 17, 2009
Examiner
HWANG, JOHN C B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with A ALS ASSOCIATION TREAT ALS TRANSLATIONAL RESEARCH ADVANCING THERAPY FOR ALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Pickerill

JOHN PICKERILL FREDRIKSON & BYRON, P.A.200 S 6TH ST STE 4000MINNEAPOLIS, MN 55402-1425UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Association services, namely, promoting public awareness of the need for research and funding for amyotrophic lateral sclerosis by providing information in the field of amyotrophic lateral sclerosisSECTION 8 - CANCELLEDJan 31, 2007
036Charitable fund raising; charitable fund raising services for funding research programs, patient services programs, clinical centers, and related programs and activities relating to the treatment of and finding a cure of amyotrophic lateral sclerosis; financial sponsorship of research in the field of amyotrophic lateral sclerosisSECTION 8 - CANCELLEDJan 31, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 18, 2015C8..CANCELLED SEC. 8 (6-YR)—
Feb 17, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 12, 2009REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Jan 9, 2009CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 9, 2009SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 9, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 19, 2008IUAFUSE AMENDMENT FILED—
Dec 19, 2008EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 24, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 1, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 12, 2008NPUBNOTICE OF PUBLICATION—
Feb 22, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 21, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 20, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 20, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 20, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2007ALIEASSIGNED TO LIE—
Aug 20, 2007GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 20, 2007GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 20, 2007CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 17, 2007DOCKASSIGNED TO EXAMINER—
May 12, 2007MDSMNOTICE OF DESIGN SEARCH CODE MAILED—
May 11, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance